Ameritas Investment Partners, Inc. Assembly Biosciences, Inc. Transaction History

Ameritas Investment Partners, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$3.8 - $4.56 $9,393 - $11,272	-2,472 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$14.57 - $23.96 $5,973 - $9,823	410 Added 19.88%	2,472 $58,000
Q1 2020 May 13, 2020	BUY	$10.27 - $21.23 $3,758 - $7,770	366 Added 21.58%	2,062 $31,000
Q3 2018 Nov 13, 2018	BUY	$34.41 - $44.23 $10,839 - $13,932	315 Added 22.81%	1,696 $63,000
Q1 2018 May 15, 2018	BUY	$41.7 - $64.16 $6,255 - $9,624	150 Added 12.19%	1,381 $68,000
Q2 2017 Aug 15, 2017	BUY	N/A	1,231	1,231 $25,000

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $822M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.